Urticaria Chronic

2

Review clinical trials related to Urticaria Chronic. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Mediterranean and Low-Histamine Diets for Pediatric Chronic Spontaneous Urticaria

Chronic spontaneous urticaria (CSU) is a chronic inflammatory skin disease that can substantially impair quality of life in children and adolescents. Pharmacological treatment may not adequately control symptoms in all patients, increasing interest in dietary interventions. This randomized controlled trial aims to compare the effects of a Mediterranean diet and a low-histamine diet, in addition to standard medical treatment, on disease activity, disease control, and quality of life in pediatric patients aged 12-18 years with chronic spontaneous urticaria. Participants will be allocated to one of three groups: standard treatment alone, standard treatment plus a low-histamine diet, or standard treatment plus a Mediterranean diet. The dietary intervention will last four weeks, with follow-up through eight weeks.

Participants needed: 63
Trial details
Age: 12-18Biological sex: AllType: InterventionalSponsor: Saglik Bilimleri UniversitesiUpdated: Aug 14, 2026Locations: 1
Eligibility criteria

Age 12-18 years. Confirmed diagnosis of Chronic Spontaneous Urticaria (CSU) acco...

Presence of a neurodevelopmental disorder. Presence of any other known chronic d...

Status: Recruiting

An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria

This is a Phase 2b, outpatient, single-dose, randomized, double blind, placebo-controlled, three period crossover study that will consist of a screening period and three blinded treatment periods. Subjects enrolled will have CSU with a history of moderate to severe acute exacerbations (or flares).

Participants needed: 42
Trial details
Phase: Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: ARS Pharmaceuticals, Inc.Updated: Jul 22, 2026Locations: 3
Eligibility criteria

Is a male or female between the ages of 18 and 65 years, inclusive. [+12]

Has a history of clinically significant gastrointestinal, renal, hepatic, neurol... [+6]